Clopidogrel 600 mg and 300 mg as a Loading Dose Prior to Percutaneous Coronary Intervention And Serum Troponin Level Elevation: A Pilot Study

Trial Profile

Clopidogrel 600 mg and 300 mg as a Loading Dose Prior to Percutaneous Coronary Intervention And Serum Troponin Level Elevation: A Pilot Study

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Aug 2008

At a glance

  • Drugs Clopidogrel (Primary)
  • Indications Coronary disorders; Coronary thrombosis
  • Focus Biomarker; Pharmacodynamics
  • Acronyms CASTLE
  • Sponsors Sanofi
  • Most Recent Events

    • 06 Aug 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top